1-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-pyrazole → 2-Amino-5-(3-pyrazol-1-yl-phenyl)-N-pyridazin-4-yl-nicotinamide
Reaction equation
[NH2:1][C:2]1[N:16]=[CH:15][C:14](Br)=[CH:13][C:3]=1[C:4]([NH:6][C:7]1[CH:12]=[CH:11][N:10]=[N:9][CH:8]=1)=[O:5].CC1(C)C(C)(C)OB([C:26]2[CH:27]=[C:28]([N:32]3[CH:36]=[CH:35][CH:34]=[N:33]3)[CH:29]=[CH:30][CH:31]=2)O1>>[NH2:1][C:2]1[N:16]=[CH:15][C:14]([C:26]2[CH:31]=[CH:30][CH:29]=[C:28]([N:32]3[CH:36]=[CH:35][CH:34]=[N:33]3)[CH:27]=2)=[CH:13][C:3]=1[C:4]([NH:6][C:7]1[CH:12]=[CH:11][N:10]=[N:9][CH:8]=1)=[O:5]Participants
3
Procedure
Reaction of 2-amino-5-bromo-N-pyridazin-4-yl-nicotinamide (see step 1 in the synthesis of “A16”) and 1-[3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-1H-pyrazole gives the compound “A18”;
Workup
- customgives the compound “A18”
Sources & evidence
- ORD record
- ord-bf5a1c3704db4471919b9719c888f9e8
- Source dataset
- uspto-grants-2016_03
- Patent number
- US09273029B2
Reaction notes
Loading…